<VariationArchive VariationID="1073581" VariationName="NM_001164508.2(NEB):c.24176_24179dup (p.Lys8061fs)" VariationType="Duplication" Accession="VCV001073581" Version="8" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-03-17" DateCreated="2021-05-10" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1058936" VariationID="1073581">
      <GeneList>
        <Gene Symbol="NEB" FullName="nebulin" GeneID="4703" HGNC_ID="HGNC:7720" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>2q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="151485339" stop="151734476" display_start="151485339" display_stop="151734476" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="152341852" stop="152591000" display_start="152341852" display_stop="152591000" Strand="-" />
          </Location>
          <OMIM>161650</OMIM>
        </Gene>
        <Gene Symbol="RIF1" FullName="replication timing regulatory factor 1" GeneID="55183" HGNC_ID="HGNC:23207" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>2q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="151409902" stop="151534435" display_start="151409902" display_stop="151534435" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="152266396" stop="152333859" display_start="152266396" display_stop="152333859" Strand="+" />
          </Location>
          <OMIM>608952</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001164508.2(NEB):c.24176_24179dup (p.Lys8061fs)</Name>
      <CanonicalSPDI>NC_000002.12:151498287:ACTC:ACTCACTC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>2q23.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="151498287" stop="151498288" display_start="151498287" display_stop="151498288" variantLength="4" positionVCF="151498287" referenceAlleleVCF="G" alternateAlleleVCF="GACTC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="152354801" stop="152354802" display_start="152354801" display_stop="152354802" variantLength="4" positionVCF="152354801" referenceAlleleVCF="G" alternateAlleleVCF="GACTC" />
      </Location>
      <ProteinChange>K8061fs</ProteinChange>
      <ProteinChange>K8096fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_202t1" sequenceAccession="LRG_202t1">
            <Expression>LRG_202t1:c.24281_24284dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_202" sequenceAccession="LRG_202">
            <Expression>LRG_202:g.241197_241200dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001164507.2" sequenceAccession="NM_001164507" sequenceVersion="2" change="c.24176_24179dup" MANEPlusClinical="true">
            <Expression>NM_001164507.2:c.24176_24179dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001157979.2" sequenceAccession="NP_001157979" sequenceVersion="2" change="p.Lys8061fs">
            <Expression>NP_001157979.2:p.Lys8061fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001164508.2" sequenceAccession="NM_001164508" sequenceVersion="2" change="c.24176_24179dup" MANESelect="true">
            <Expression>NM_001164508.2:c.24176_24179dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001157980.2" sequenceAccession="NP_001157980" sequenceVersion="2" change="p.Lys8061fs">
            <Expression>NP_001157980.2:p.Lys8061fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001271208.2" sequenceAccession="NM_001271208" sequenceVersion="2" change="c.24281_24284dup">
            <Expression>NM_001271208.2:c.24281_24284dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001258137.2" sequenceAccession="NP_001258137" sequenceVersion="2" change="p.Lys8096fs">
            <Expression>NP_001258137.2:p.Lys8096fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004543.5" sequenceAccession="NM_004543" sequenceVersion="5" change="c.18826-1923_18826-1920dup">
            <Expression>NM_004543.5:c.18826-1923_18826-1920dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.152354802_152354805dup" Assembly="GRCh37">
            <Expression>NC_000002.11:g.152354802_152354805dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.151498288_151498291dup" Assembly="GRCh38">
            <Expression>NC_000002.12:g.151498288_151498291dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009382.2" sequenceAccession="NG_009382" sequenceVersion="2" change="g.241197_241200dup">
            <Expression>NG_009382.2:g.241197_241200dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001271208.2" sequenceAccession="NM_001271208" sequenceVersion="2" change="c.24281_24284dupGAGT">
            <Expression>NM_001271208.2:c.24281_24284dupGAGT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2061721973" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00000" Source="Trans-Omics for Precision Medicine (TOPMed)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001164508.2(NEB):c.24176_24179dup (p.Lys8061fs) AND Nemaline myopathy 2" Accession="RCV001386615" Version="4">
        <ClassifiedConditionList TraitSetID="3882">
          <ClassifiedCondition DB="MedGen" ID="C1850569">Nemaline myopathy 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-05-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001164508.2(NEB):c.24176_24179dup (p.Lys8061fs) AND not provided" Accession="RCV001780355" Version="4">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-04-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001164508.2(NEB):c.24176_24179dup (p.Lys8061fs) AND Arthrogryposis multiplex congenita 6" Accession="RCV003469722" Version="1">
        <ClassifiedConditionList TraitSetID="66961">
          <ClassifiedCondition DB="MedGen" ID="C5543431">Arthrogryposis multiplex congenita 6</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-04-22" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001164508.2(NEB):c.24176_24179dup (p.Lys8061fs) AND Nemaline myopathy" Accession="RCV003490238" Version="1">
        <ClassifiedConditionList TraitSetID="12233">
          <ClassifiedCondition DB="MedGen" ID="C0206157">Nemaline myopathy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-15" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2021-05-10" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">25205138</ID>
        </Citation>
        <DescriptionHistory Dated="2023-12-29">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="66961" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="56163" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Arthrogryposis multiplex congenita 6</ElementValue>
                <XRef ID="MONDO:0030281" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">AMC6</ElementValue>
                <XRef Type="MIM" ID="619334" DB="OMIM" />
              </Symbol>
              <XRef ID="C5543431" DB="MedGen" />
              <XRef ID="MONDO:0030281" DB="MONDO" />
              <XRef Type="MIM" ID="619334" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3882" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5618" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Nemaline myopathy 2, autosomal recessive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nemaline myopathy caused by mutation in the nebulin gene</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Nemaline myopathy 2</ElementValue>
                <XRef ID="Nemaline+myopathy+2/5124" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009725" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NEM2</ElementValue>
                <XRef Type="MIM" ID="256030" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15209" />
                <XRef ID="15209" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2012">
                <ID Source="PubMed">22510848</ID>
              </Citation>
              <XRef ID="C1850569" DB="MedGen" />
              <XRef ID="MONDO:0009725" DB="MONDO" />
              <XRef Type="MIM" ID="256030" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="12233" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9537" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Rod myopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Nemaline myopathy</ElementValue>
                <XRef ID="MONDO:0018958" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS161800" DB="OMIM" />
                <XRef ID="75072002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myopathies, Nemaline</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12033" />
                <XRef ID="12033" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2011">
                <URL>http://www.acmg.net/ACMG/UploadedPDFS/PDFDocuments/Carrier-Screening-ACT-SheetAshkenazi-Jewish-Genetic-Disorders.aspx</URL>
                <CitationText>American College of Medical Genetics ACT Sheet, Carrier Screening ACT Sheet Ashkenazi Jewish Genetic Disorders</CitationText>
              </Citation>
              <XRef ID="607" DB="Orphanet" />
              <XRef ID="C0206157" DB="MedGen" />
              <XRef ID="MONDO:0018958" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS161800" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7844256" SubmissionDate="2023-12-07" DateLastUpdated="2023-12-30" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_001271208.1:c.24281_24284dup|OMIM:619334" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004200296" DateUpdated="2023-12-30" DateCreated="2023-12-30" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001271208.1:c.24281_24284dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="619334" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3965202" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="eaf3990a9c6d48c6568ab9f153eecb9278bb8d44579a042e4d6e4b3b55335111|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002018252" DateUpdated="2024-02-04" DateCreated="2021-11-29" Type="SCV" Version="3" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-04-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001271208.1:c.24281_24284dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10694847</SubmissionName>
          <SubmissionName>SUB12926214</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7917188" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2024-02-04">
        <ClinVarSubmissionID localKey="NM_001271208.2:c.24281_24284dupGAGT|MedGen:C0206157" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004241115" DateUpdated="2024-02-04" DateCreated="2024-02-04" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Variant summary: NEB c.24281_24284dupGAGT (p.Lys8096SerfsX9) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant was absent in 157088 control chromosomes. To our knowledge, no occurrence of c.24281_24284dupGAGT in individuals affected with Nemaline Myopathy 2 and no experimental evidence demonstrating its impact on protein function have been reported. Two submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NEB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001271208.2:c.24281_24284dupGAGT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0206157" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14175850</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3112531" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="11998247|MedGen:C1850569" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001586879" DateUpdated="2024-02-28" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25205138</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 1073581). This variant has not been reported in the literature in individuals affected with NEB-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Lys8096Serfs*9) in the NEB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NEB are known to be pathogenic (PMID: 25205138).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NEB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.152354801_152354802insACTC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1850569" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7844256" TraitType="Disease" MappingType="XRef" MappingValue="619334" MappingRef="OMIM">
        <MedGen CUI="C5543431" Name="Arthrogryposis multiplex congenita 6" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3112531" TraitType="Disease" MappingType="XRef" MappingValue="C1850569" MappingRef="MedGen">
        <MedGen CUI="C1850569" Name="Nemaline myopathy 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7917188" TraitType="Disease" MappingType="XRef" MappingValue="C0206157" MappingRef="MedGen">
        <MedGen CUI="C0206157" Name="Nemaline myopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3965202" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

